- Home
- BKR vs EW Comparison
BKR vs EW Comparison
Compare BKR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKR
- EW
- Stock Information
- Founded
- BKR 2016
- EW 1958
- Country
- BKR United States
- EW United States
- Employees
- BKR N/A
- EW N/A
- Industry
- BKR Metal Fabrications
- EW Industrial Specialties
- Sector
- BKR Industrials
- EW Health Care
- Exchange
- BKR Nasdaq
- EW Nasdaq
- Market Cap
- BKR 43.5B
- EW 42.5B
- IPO Year
- BKR N/A
- EW 2000
- Fundamental
- Price
- BKR $40.32
- EW $74.78
- Analyst Decision
- BKR Strong Buy
- EW Buy
- Analyst Count
- BKR 19
- EW 21
- Target Price
- BKR $46.47
- EW $79.40
- AVG Volume (30 Days)
- BKR 6.5M
- EW 5.6M
- Earning Date
- BKR 01-30-2025
- EW 02-04-2025
- Dividend Yield
- BKR 2.08%
- EW N/A
- EPS Growth
- BKR 33.57
- EW 193.69
- EPS
- BKR 2.23
- EW 6.89
- Revenue
- BKR $27,300,000,000.00
- EW $6,314,900,000.00
- Revenue This Year
- BKR $9.26
- EW N/A
- Revenue Next Year
- BKR $2.25
- EW $0.91
- P/E Ratio
- BKR $18.09
- EW $28.85
- Revenue Growth
- BKR 11.08
- EW 24.02
- 52 Week Low
- BKR $28.32
- EW $58.93
- 52 Week High
- BKR $45.17
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- BKR 40.45
- EW 62.35
- Support Level
- BKR $40.35
- EW $72.29
- Resistance Level
- BKR $41.83
- EW $74.58
- Average True Range (ATR)
- BKR 1.09
- EW 1.93
- MACD
- BKR -0.44
- EW 0.06
- Stochastic Oscillator
- BKR 19.38
- EW 91.36
About BKR Baker Hughes Company
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. It maintains modest exposure to offshore oil and gas production. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with a high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.